Claritas Rx, the leading provider of data and analytics solutions covering specialty and rare disease patients, today announced the closing of a significant growth equity investment from Questa Capital, a venture growth equity firm focused on investing in expansion-stage healthcare companies. The funds will be used to enhance drug and patient analytics with innovative new products, accelerate sales & marketing and expand the company’s management team.
“Claritas is illuminating the patient journey every day, revealing opportunities for our pharma clients and the broader specialty ecosystem to support patients in managing their chronic, life-sustaining therapies. This funding will allow us to invest in our existing client relationships, as well as accelerate product innovation, and expand our market reach. We are thrilled to have a partner like Questa with deep healthcare domain expertise and appreciation for our mission of using real-world data to illuminate the patient journey,” said Mike Fitzgibbons, Claritas Rx Founder and Chief Executive Officer.
Read the press release here.